Latest scientific publications

  • Adverse events and impact on quality of life of antibody-drug conjugates in the treatment of metastatic breast cancer: A systematic review and meta-analysis.

  • Auteurs Perachino M, Blondeaux E, Molinelli C, Ruelle T, Giannubilo I, Arecco L, Nardin S, Razeti MG, Borea R, Favero D, Lanzavecchia C, Chiappe E, Tomasello L, Mariamidze E, Jankovic K, Stana M, Ottonello S, Scavone G, de Moura Leite L, Spinaci S, Saura C, Lambertini M
  • Revue Eur J Clin Invest
  • Date de publication 2025-06
Adverse events and impact on quality of life of antibody-drug conjugates in the treatment of metastatic breast cancer: A systematic review and meta-analysis.
  • Olorofim for the treatment of invasive fungal diseases in patients with few or no therapeutic options: a single-arm, open-label, phase 2b study.

  • Auteurs Maertens JA, Thompson GR, Spec A, Donovan FM, Hammond SP, Bruns AHW, Rahav G, Shoham S, Johnson R, Rijnders B, Schaenman J, Hoenigl M, Morrissey CO, Mehta SR, Heath CH, Koehler P, Paterson DL, Slavin MA, Fortún J, Nguyen MH, Patterson TF, Uspenskaya O, Van de Veerdonk FL, Verweij PE, Aoun M, Georgala A, Alexander BD, Chayakulkeeree M, Mehra V, Miceli MH, Sikka MK, Solé A, Walsh TJ, Aguado JM, Holland SM, Moussa M, Rautemaa-Richardson R, Bazaz R, Schwartz S, Walsh SR, Plate M, Yehudai-Ofir D, Brüggemann RJ, Cornely OA, Ostrosky-Zeichner L, Vazquez JA, White PL, Cornelissen K, Ross GG, Fitton L, Dane A, Zinzi D, Rex JH, Chen SC
  • Revue Lancet Infect Dis
  • Date de publication 2025-06
Olorofim for the treatment of invasive fungal diseases in patients with few or no therapeutic options: a single-arm, open-label, phase 2b study.
  • Melanocytic clefting is associated with melanoma on LC-OCT.

  • Auteurs Pérez-Anker J, Soglia S, Puig S, García A, Albero R, Alejo B, Cinotti E, Orte Cano C, Habougit C, Skowron F, Pellegrino L, Tognetti L, Lenoir C, Castillo P, Rubegni P, Suppa M, Perrot JL, Del Marmol V, Alòs L, Malvehy J
  • Revue J Eur Acad Dermatol Venereol
  • Date de publication 2025-06
Melanocytic clefting is associated with melanoma on LC-OCT.
  • Independent validation and outlier analysis of EuroPOND alzheimer's disease staging model using ADNI and real-world clinical data.

  • Auteurs Wittens MMJ, Sima DM, Brys A, Struyfs H, Niemantsverdriet E, De Roeck E, Bastin C, Benoit F, Bergmans B, Bier JC, de Deyn PP, Deryck O, Hanseeuw B, Ivanoiu A, Picard G, Salmon E, Segers K, Sieben A, Thiery E, Tournoy J, van Binst AM, Versijpt J, Smeets D, Bjerke M, Bellio M, Oxtoby NP, Alexander DC, Ribbens A, Engelborghs S
  • Revue Alzheimers Res Ther
  • Date de publication 2025-06
Independent validation and outlier analysis of EuroPOND alzheimer's disease staging model using ADNI and real-world clinical data.
Bordet hospital

Jules Bordet Institute

View all of Jules Bordet's scientific publications

Erasme hospital

Erasme Hospital

View all of Erasme's scientific publications

Huderf hospital

Queen Fabiola Children's Hospital

View all scientific publications from the Queen Fabiola Children's Hospital